These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35718019)

  • 61. PEGylated graphene oxide-mediated quercetin-modified collagen hybrid scaffold for enhancement of MSCs differentiation potential and diabetic wound healing.
    Chu J; Shi P; Yan W; Fu J; Yang Z; He C; Deng X; Liu H
    Nanoscale; 2018 May; 10(20):9547-9560. PubMed ID: 29745944
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Emerging translational research on magnetic nanoparticles for regenerative medicine.
    Gao Y; Lim J; Teoh SH; Xu C
    Chem Soc Rev; 2015 Oct; 44(17):6306-29. PubMed ID: 26505058
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent Developments in Nano-Formulations Against Diabetes.
    Choudhury S; Patra P
    Recent Pat Nanotechnol; 2023; 17(4):340-358. PubMed ID: 35733310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanomaterials for Engineering Stem Cell Responses.
    Kerativitayanan P; Carrow JK; Gaharwar AK
    Adv Healthc Mater; 2015 Aug; 4(11):1600-27. PubMed ID: 26010739
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pancreatic progenitors: The shortest route to restore islet cell mass.
    Venkatesan V; Gopurappilly R; Goteti SK; Dorisetty RK; Bhonde RR
    Islets; 2011; 3(6):295-301. PubMed ID: 21934353
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nanoscale surfacing for regenerative medicine.
    Yang Y; Leong KW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):478-95. PubMed ID: 20803682
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions.
    Augustine R; Prasad P; Khalaf IMN
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():994-1008. PubMed ID: 30678987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications.
    La Francesca S
    Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):28-35. PubMed ID: 22891108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. From tissue to human regeneration: the development of a comprehensive regenerative care clinic for people with diabetes.
    Hargraves IG; Behfar A; Simha V; Donoghue C; Renner AS; Montori VM; Brito JP
    Regen Med; 2021 Mar; 16(3):219-228. PubMed ID: 33724876
    [No Abstract]   [Full Text] [Related]  

  • 70. Concise review: mesenchymal stem cells for diabetes.
    Domínguez-Bendala J; Lanzoni G; Inverardi L; Ricordi C
    Stem Cells Transl Med; 2012 Jan; 1(1):59-63. PubMed ID: 23197641
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stem cells and growth factors-based delivery approaches for chronic wound repair and regeneration: A promise to heal from within.
    Sharma P; Kumar A; Dey AD; Behl T; Chadha S
    Life Sci; 2021 Mar; 268():118932. PubMed ID: 33400933
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nanostructured scaffold as a determinant of stem cell fate.
    Krishna L; Dhamodaran K; Jayadev C; Chatterjee K; Shetty R; Khora SS; Das D
    Stem Cell Res Ther; 2016 Dec; 7(1):188. PubMed ID: 28038681
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nanotechnologies in regenerative medicine.
    Kubinová S; Syková E
    Minim Invasive Ther Allied Technol; 2010 Jun; 19(3):144-56. PubMed ID: 20497067
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
    Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
    Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nanotechnology in Kidney and Islet Transplantation: An Ongoing, Promising Field.
    Wang W; Teng Y; Xue JJ; Cai HK; Pan YB; Ye XN; Mao XL; Li SW
    Front Immunol; 2022; 13():846032. PubMed ID: 35464482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nanotechnology and picotechnology to increase tissue growth: a summary of in vivo studies.
    Alpaslan E; Webster TJ
    Int J Nanomedicine; 2014; 9 Suppl 1(Suppl 1):7-12. PubMed ID: 24872699
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Electrospinning: An enabling nanotechnology platform for drug delivery and regenerative medicine.
    Chen S; Li R; Li X; Xie J
    Adv Drug Deliv Rev; 2018 Jul; 132():188-213. PubMed ID: 29729295
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic approaches based on beta-cell mass preservation and/or regeneration.
    Ritzel RA
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1835-50. PubMed ID: 19273167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advances and complications of regenerative medicine in diabetes therapy.
    Brovkina O; Dashinimaev E
    PeerJ; 2020; 8():e9746. PubMed ID: 33194345
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current progress and perspectives in cell therapy for diabetes mellitus.
    Miyamoto M
    Hum Cell; 2001 Dec; 14(4):293-300. PubMed ID: 11925931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.